Evidence map›Paper›PMID 33776422›Full record

ArticleDrug design, development and therapy2021

Study on the Mechanism of Jiawei Shengjiang Powder in Improving Male Asthma-Induced Asthenospermia Based on Network Pharmacology and Bioinformatics.

Ji-Sheng Wang, Xue-Feng Gong, Jun-Long Feng, Hai-Song Li, Xiao Li, Sheng Deng, Pei-Zhong Ren, Jia-Mei Wang, Ming-Sheng Lv, Rui-Feng Jin and 3 more

Open access · goldAbstract read
In one paragraph

Article in Drug design, development and therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. An Updated Comprehensive Review of Plants and Herbal Compounds with Antiasthmatic Effect.Evidence-based complementary and alternative medicine : eCAM · 2024
    Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Ji-Sheng Wang *First Clinical Medical College, Beijing University of Chinese Medicine, Beijing, 100029, People's Republic of China.
Xue-Feng Gong *The Third Affiliated Hospital of Beijing University of Chinese Medicine, Beijing, 100029, People's Republic of China.
Jun-Long Feng *First Clinical Medical College, Beijing University of Chinese Medicine, Beijing, 100029, People's Republic of China.
Hai-Song LiAndrology Department, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, People's Republic of China.
Xiao LiDepartment of Andrology, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, 450046, People's Republic of China.
Sheng DengFirst Clinical Medical College, Beijing University of Chinese Medicine, Beijing, 100029, People's Republic of China.
Pei-Zhong RenThe Third Affiliated Hospital of Beijing University of Chinese Medicine, Beijing, 100029, People's Republic of China.
Jia-Mei WangThe Third Affiliated Hospital of Beijing University of Chinese Medicine, Beijing, 100029, People's Republic of China.
Ming-Sheng LvThe Third Affiliated Hospital of Beijing University of Chinese Medicine, Beijing, 100029, People's Republic of China.
Rui-Feng JinThe Third Affiliated Hospital of Beijing University of Chinese Medicine, Beijing, 100029, People's Republic of China.
Qiu-Yi ChenThe Third Affiliated Hospital of Beijing University of Chinese Medicine, Beijing, 100029, People's Republic of China.
Bin WangAndrology Department, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, People's Republic of China.
Hong-Sheng CuiPneumology Department, The Third Affiliated Hospital of Beijing University of Chinese Medicine, Beijing, 100029, People's Republic of China.
Beijing University of Chinese Medicine · CNDongzhimen Hospital Affiliated to Beijing University of Chinese Medicine · CNFirst Affiliated Hospital of Henan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundJiawei Shengjiang Powder (JWSJP) is a classical Chinese medicinal formula, which has been widely applied in the treatment of asthma and complications for many years due to its curative effect.

aimTo verify the effect of JWSJP in improving abnormal sperm motility caused by asthma and to explore its potential mechanism. MATERIALS AND

methodsThe active compounds of JWSJP were obtained from high performance liquid chromatography tandem mass spectrometry and the Traditional Chinese Medicine System Pharmacology. The key active components and targets of JWSJP were predicted based on network pharmacological analysis and bioinformatics research. Rats were randomly divided into normal, model and treatment groups. The rat model of allergic asthma was induced by intraperitoneal injection of ovalbumin solution. The experiment judged improvement of semen quality by evaluating sperm motility, and detected the expression of related proteins in testicular tissue of Sprague-Dawley rats by RT-qPCR and Western blot methods. Hematoxylin and eosin (HE) staining was used to observe the changes in testicular tissue structure in rats.

resultsThrough the analysis of network pharmacology and bioinformatics, it was found that beta-sitosterol, quercetin, gallic acid, pelargonidin and kaempferol were the key active components of Jiawei Shengjiang Powder. Tumor necrosis factor (TNF), interleukin-6 (IL-6) and insulin (INS) genes are crucial targets of JWSJP in the treatment of spermatogenic dysfunction caused by acute asthma. After 8 weeks of intervention, compared with the model group, the treatment group had significantly improved sperm motility (P < 0.05). There were significant differences in TNF, IL6, and INS proteins in the treatment group, and the HE staining of testicular tissue structure in the treatment group was significantly improved.

conclusionJWSJP can improve the abnormal sperm motility induced by asthma, and its mechanism may be related to the expression of related proteins and mRNA of TNF, IL6, and INS.

Indexed as

Computational BiologyAnimalsAsthenozoospermiaAsthmaDisease Models, AnimalDrugs, Chinese HerbalMaleMedicine, Chinese TraditionalOvalbuminPowdersRatsRats, Sprague-DawleySperm MotilityDrugs, Chinese HerbalOvalbuminPowdersasthenospermiaasthmatic attackJiawei Shengjiang Powdernetwork pharmacology

Identifiers

PMID33776422
PMCPMC7989703
OpenAlexW3136710133

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.